Previous 10 | Next 10 |
2023-11-09 03:33:33 ET More on Myriad Genetics Myriad Genetics: FRα Addition Further Diversifies Portfolio Myriad Genetics proposes offering of $100M of shares of common stock Seeking Alpha’s Quant Rating on Myriad Genetics For further details s...
SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing and precision medicine, today announced the pricing of an upsized underwritten public offering of 6,470,588 shares o...
2023-11-08 16:28:16 ET More on Myriad Genetics Myriad Genetics, Inc. (MYGN) Q3 2023 Earnings Call Transcript Myriad Genetics: FRα Addition Further Diversifies Portfolio Seeking Alpha’s Quant Rating on Myriad Genetics Historical earnings data for...
SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a leader in genetic testing and precision medicine, today announced that it plans to make a public offering of $100.0 million of shares of its c...
2023-11-06 19:35:26 ET Myriad Genetics, Inc. (MYGN) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Matt Scalo - Senior Vice President, Investor Relations Paul Diaz - President and Chief Executive Officer Mark Verratti - Chief Co...
2023-11-06 16:17:21 ET More on Myriad Genetics Myriad Genetics: FRα Addition Further Diversifies Portfolio Seeking Alpha’s Quant Rating on Myriad Genetics Historical earnings data for Myriad Genetics Financial information for Myriad Genetics ...
Highlights: Third quarter testing volume grew 18% year-over-year, excluding contributions from the SneakPeek ® Early Gender DNA Test, the fifth consecutive quarter of double-digit year-over-year growth. In the third quarter and year-to-date: ...
CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...
Myriad Genetics Inc. (MYGN) is expected to report $-0.16 for Q3 2023
2023-11-01 09:19:33 ET More on Myriad Genetics Myriad Genetics: FRα Addition Further Diversifies Portfolio Myriad Genetics, Inc. (MYGN) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Myriad Genetics Historical earnings data for...
News, Short Squeeze, Breakout and More Instantly...
SALT LAKE CITY, July 31, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Jennifer Fox as Chief Legal Officer, effective September 3, 2024. Fox brings nearly two decades of legal experi...
SALT LAKE CITY, July 30, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its second quarter earnings conference call on Tuesday, August 6, 2024 at 4:30pm ET. The company’s quarterly earnings will be released ...
2024-07-23 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...